The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2027-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome

NCT03773263

Polycystic Ovary Syndrome Infertility

UNKNOWN PHASE3

In Vitro Maturation (IVM) of Human Oocytes

NCT01843569

Polycystic Ovarian Syndrome (PCOS) Patients Sensitive to Exogenous Gonadotropins Ovarian Hyper Stimulation Syndrome (OHSS)

WITHDRAWN NA

In Vitro Maturation (IVM) of Human Oocytes

NCT01550861

Infertility

TERMINATED NA

DUOSTIM and AI: is There a Difference Between Oocyte Performance in the Follicular and Luteal Phases?

NCT06799598

Infertility

COMPLETED

The Difference Seen in Granulosa Cells and Immature Oocytes in IVF Treated Patients Sorted by Body Mass Index (BMI)

NCT03020173

Infertility, Female

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction Magenta™ is a software image analysis tool developed by Future Fertility that allows personalized reproductive prediction for each oocyte (egg cell) analyzed. It is a cloud-based software that was developed to assess the probability of an oocyte to fertilize and develop into a blastocyst (ball of rapidly dividing cells that will become an embryo). It is a non-invasive image analysis tool that uses artificial intelligence (AI) to predict outcomes based on a single 2-D image of a mature oocyte (denuded oocyte) prior to freezing or sperm injection (ICSI). Magenta™ was designed and built specifically to analyze oocytes in the IVF lab. It was created based on more than 20,000 images of oocytes and their known reproductive outcomes. It is an image analysis neural network that can identify important signals beyond the limited morphological features detected by embryologists, like facial recognition systems in use today. Without the development of this AI tool, there are no standard assessments for oocyte quality within the IVF process. The use of Magenta™ in this study is investigational.

In standard IVF laboratories, oocytes can undergo their developmental period alone (single culture) or be grouped with other oocytes during this time (group culture). Research has shown that group culture has some developmental advantages over single culture.

What is this study for? At the moment, there is no standard method to sort oocytes into groups for their developmental period. Currently, oocytes are sorted in a random manner. We hope that Magenta™ analysis will provide information at this early stage of development and inform a better way to sort oocytes into groups (from lowest to highest quality). The objective of this research study is to compare sorting the oocytes randomly to utilizing the MagentaTM tool for oocyte assessment to determine which oocytes should be grouped together. Study participants will be randomly assigned to the control (random sorting) or the study (Magenta™ analysis) groups at the time of oocyte retrieval. You have an equal chance of being assigned to either group. We intend to enroll 450 subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Primary

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oocytes with AI

Oocytes assessed by the Magenta software

Magenta AI image analysis tool

Intervention Type OTHER

MagentaTM is a non-invasive image analysis tool that utilizes artificial intelligence to evaluate 2-dimensional images of denuded mature MII oocytes. The MagentaTM software has been analyzed retrospectively, by Future Fertility. This data displays that a higher MagentaTM score is associated with a higher chance of blastocyst development. Additionally, the MagentaTM software has been validated in a prospective multi-center study, displaying that a higher MagentaTM score correlates to a higher chance of blastocyst development.

Oocytes without AI

Oocytes randomly selected

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magenta AI image analysis tool

MagentaTM is a non-invasive image analysis tool that utilizes artificial intelligence to evaluate 2-dimensional images of denuded mature MII oocytes. The MagentaTM software has been analyzed retrospectively, by Future Fertility. This data displays that a higher MagentaTM score is associated with a higher chance of blastocyst development. Additionally, the MagentaTM software has been validated in a prospective multi-center study, displaying that a higher MagentaTM score correlates to a higher chance of blastocyst development.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Fresh MII oocytes
* ICSI cycles with patient's or donor's sperm
* Patient's or donor's oocytes
* Full IVF cycle information available (including total number of oocytes retrieved, total MII oocytes, fertilization, embryo and blastocyst development, as well as ploidy status or implantation results, and 6-7 week ultrasound, if applicable)
* Good quality images of MII oocytes taken with a specified camera (Basler) and Future Fertility Software
* Single embryo transfers (SETs) at blastocyst stage.
* Blastocyst freeze-all cycles

Exclusion Criteria

* Severe male factor infertility (\<1 million motile), including surgically retrieved sperm.
* ICSI cycles inseminating in vitro matured (IVM) oocytes
* Rescue ICSI oocytes (oocytes failed standard IVF and are re-inseminated by ICSI)
* Low quality images - Poor quality images on day of upload or before unblinding
* Lack of correlating reproductive outcomes (full IVF lab results not available).
* Autologous or donor frozen/warmed oocytes
* Day 3 embryo transfers or cleavage stage embryo freezing
* Patients with less than 6 mature oocytes

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes